Ready2Respond takes a ‘problem identification-solution design’ approach to close downstream gaps in vaccine delivery programs. Our projects aim to foster lasting change by increasing vaccine uptake while strengthening and enhancing adult vaccination programs.
Projects fall within 3 strategic pillars of work:
Burden of disease
Data from hospital sites that participate in the Global Influenza Hospital Surveillance Network (GIHSN) have been analyzed to compare influenza burden disparities in hospitalized patients between high, middle, and low-income countries.
Our partners at the London School of Hygiene & Tropical Medicine are conducting a cost-effective analysis of current and next-generation influenza vaccines in select countries through the development of a mathematical model that projects the full health and economic impact of vaccines.
The VaxDemandTool has been developed by Ready2Respond with support from PricewaterhouseCoopers. The tool allows countries to simulate the evolution of their influenza vaccine demand for up to five consecutive years and to create country-specific pandemic influenza vaccine demand scenarios. Countries may use this tool to document estimates of the number of vaccine doses needed, for when, and for whom. Access the tool here.
Research being conducted by Sabin Vaccine Institute will determine the most high-yield activities of influenza programs that have increased vaccination coverage rates (VCR) and how flu programs have contributed to COVID-19 response in select middle-income countries (MIC).
Projects will likely be initiated in 2023.